The oncogenes resulting from RET rearrangements found exclusively in human papillary thyroid carcinoma (PC) are referred to as PTC oncogenes (papillary thyroid carcinoma). To date, at least 11 different PTC oncogenes, differing in their N-terminal donor genes, have been identified (reviewed in Tallini and Asa, 2001 ). For PC patients with no previous radiation exposure, PTC1 is the most frequent form of PTC oncogene. PTC1 is a fusion oncoprotein that is comprised of the N-terminal coding sequence of H4, containing a coiled-coil motif, fused to the C-terminal coding sequence of RET, containing a tyrosine kinase domain. This PTC1 oncoprotein has been shown to be located in the cytoplasm, able to form homodimers, constitutively tyrosine phosphorylated, and able to induce a transformed phenotype in NIH3T3 cells (reviewed in van Weering and Bos, 1998; Jhiang, 2000) . We have shown that targeted expression of PTC1 in the thyroid gland leads to the development of thyroid carcinoma in transgenic mice with histologic and cytologic similarities to human PC (Jhiang et al., 1996) . We further identified an increased proliferation rate, altered thyroid follicle morphogenesis, and reduced radioiodide-trapping activity as early cellular abnormalities induced by the PTC1 oncoprotein preceding tumor formation (Cho et al., 1999) . These findings provide a model for the direct role of PTC1 in the formation of abnormal follicles with reduced iodide-trapping activity observed in human PC.
RET mediated signaling pathways have been mainly studied by either transfection of cultured cells with constitutively activated RET oncoproteins (RET/PTC, RET/MEN2A, and RET/MEN2B), or by ligandinduced RET activation in cells expressing EGFR/ RET chimeric receptor or wild type RET. Since RET is a receptor tyrosine kinase, most of its signaling pathways are mediated by phosphotyrosine (pY) residues in the intracellular domain of activated RET. Recent studies indicate that the signaling pathways mediated by pY905, pY1015, and pY1062 (corresponding to pY294, pY404, and pY451 in PTC1) are critical for mitogenic or transforming activity induced by RET activation in cultured cells (reviewed in van Weering and Bos, 1998; Jhiang, 2000) . To investigate the roles of the signal transduction pathways mediated by these pY residues in PTC1-induced thyroid tumor formation in vivo, transgenic mice with thyroid-targeted expression of PTC1-Y294F, PTC1-Y404F, or PTC1-Y451F were generated and characterized. Transgene expression in mouse thyroid glands was verified by RT -PCR and Western blot analysis (Figure 1 ) in six Tg-PTC1-Y294F lines, four Tg-PTC1-Y404F lines, and 12 Tg-PTC1-Y451F lines. Both macroscopic and microscopic analyses of mouse thyroid tissues were performed to evaluate the histological grades and tumor formation. As shown in Figures 2 and 3, thyroid sections from both mice fed a normal diet and mice fed LID/PTU were evaluated and classified, with normal histology graded as '1', with distorted follicles as '2', and with tumor formation as '3'. Both intra-and inter-line variations in histological grades were observed in all PTC1-Y/F transgenic mice.
For Tg-PTC1-Y294F mice a total of 49 thyroids were investigated. Ages ranged from 2.0 to 19.5 months for normal diet studies (mean: 6.7 months), and 3.7 to 13.0 months for LID/PTU studies (mean: 6.3 months). The histological grades of different transgenic lines fed with a normal diet ranged from mean grade of 1.0+0.0 (mean+standard deviation) to 1.9+0.4. Mice fed with a LID/PTU diet ranged from 1.0+0.0 to 2.0+0.7. As indicated in Table 1 , the mean histological grades for the Tg-PTC1-Y294F group were 1.4+0.6 for mice fed a normal diet, and 1.5+0.7 for mice fed LID/PTU. A total of 39 thyroids of Tg-PTC1-Y404F mice were graded. Ages ranged from 2.0 to 12.8 months in the normal diet group (mean: 7.0 months) and 2.5 to 12.9 months in the LID/PTU group (mean: 7.0 months). The histological grades ranged from 1.0+0.0 to 3.0+0.0 for normal diet groups, and 1.5+0.7 to 2.5+1.0 for the LID/PTU groups. The mean histological grades were 1.9+0.9 and 2.3+0.8 for the normal and LID/PTU diet groups, respectively (Table 1) . A total of 123 thyroids from Tg-PTC1-Y451F mice were characterized. Ages ranged from embryological day 16.5 to 16.5 months for the normal diet group (mean: 8.2 months), and from 4 to 15.8 months for the LID/PTU group (mean: 7.3 months). The histological grades ranged from 1.0+0.0 to 3.0+0.0 for normal diet mice, and 1.0+0.0 to 2.6+0.5 for LID/PTU treated mice. The mean grades were 1.8+0.9 and 1.9+0.8, respectively, for normal diet and LID/PTU groups (Table 1) .
In contrast to the 100% tumor formation rate in Tg-PTC1 transgenic mice, Tg-PTC1-Y/F mice had lower tumor formation rates, 6, 41, or 30% for Y294F, Y404F, or Y451F mice, respectively (Table 1) . For comparison, non-transgenic (NTG) mice had a mean histological grade of 1.1 (normal diet) to 1.2 (LID/ (Xing et al., 1998) . The PTC1-Y/F cDNAs were subcloned into the pRC-CMV-Tg-PTC1 transgene and the transgenic mice were generated as described previously (Jhiang et al., 1996) . Transgene expression within thyroids was investigated by reverse transcription (RT) -PCR analysis of thyroid RNA as described in Jhiang et al. (1996) . PCR amplification of the expressed transgene was carried out using either mouse thyroid cDNA or RNA (as a control for genomic DNA contamination) as template. A 265 bp cDNA fragment of mouse b 2 microglobulin was also amplified to ensure RNA/cDNA integrity. For Western blot analysis, frozen mouse thyroid tissues were homogenized in Trizol (GibcoBRL), and total protein was extracted following the manufacturer's protocol. Extracted proteins were resolved on a 7.5% acrylamide gel, and then transferred to a nitrocellulose filter. The filters were probed with anti-RET (C1 mouse monoclonal anti-RET antibody) primary antibody followed by appropriate secondary antibody and ECL substrate solution (Amersham). The filters were then exposed to radiographic film for various lengths of time to detect the signals Statistical analysis was performed at the Ohio State University Biostatistics Core. Chi-square analysis and Fisher's exact tests were used to compare the frequency distributions of the histological grades among different transgene groups. Polytomous logistic regression analysis was used to identify differences in frequency distribution among select groups of mice. Mean+s.d.: the mean histological grade with standard deviation per transgenic group and diet. L/P: Low iodine diet supplemented with propylthiouracil. NTG: nontransgenic mice. The total number of mice observed per group is followed by the percentage amount shown in parentheses. The Pvalue reflects a significant difference in percentages of tumor formation rates among different transgenic Y/F mice. a Overall Chisquare test P50.0001 pY-294, 404 and 451 in RET/PTC1-induced thyroid tumor TLF Buckwalter et al PTU diet), with 1.8% of mice forming tumors. The fact that none of these three PTC1-Y/F mutants delivered consistent in vivo transforming activity as PTC1 indicates that signaling pathways mediated by pY294, pY404, and pY451 do play a role in PTC1-induced thyroid tumor formation. Furthermore, pY294 appears to play the most significant role towards PTC1-mediated tumor formation, followed by pY451 and pY404. Similarly, in the context of oncogenic form of RET/MEN2A, Y905F mutation (Y294F in PTC1) greatly reduced its cell-transforming activity, while Y1062F mutation (Y451F in PTC1) moderately reduced and Y1015F mutation (Y404F in PTC1) did not affect RET/MEN2A transforming activity (Kato et al., 2002) . However, as tumors are still able to form in some transgenic mice from all three single mutant transgenic groups, it would appear that the signaling pathways mediated by one of these three pYs can be Figure 2 Hematoxylin and eosin staining of thyroid glands from Tg-PTC1-Y/F transgenic mice fed a normal diet (a -f) or LID/ PTU (a* -f*). Grade 1 thyroids of normal diet mice were composed of cuboidal follicular epithelial cells organized into round follicles containing colloid (a), while LID/PTU thyroids displayed hypertrophic and hyperplastic masses of columnar follicular epithelial cells with the absence of colloid (a*). Grade 2 thyroids of normal diet mice had a portion of the gland consisting of irregularly shaped follicles comprised of cuboidal epithelium (b -c), while LID/PTU thyroids had irregularly shaped follicles existing among collapsed follicles, with either cuboidal or columnar epithelium (b* -c*). Grade 3 thyroids of normal diet mice consisted predominantly of irregular follicular structures, intermixed infrequently with round follicles (d -f). The epithelial structure varied from cuboidal in the round follicle regions, to columnar in hyperplastic regions, to spindle shape in a few samples displaying an anaplastic appearance. Grade 3 thyroids of LID/PTU mice were either collapsed consisting of hypertrophic, hyperplastic columnar or spindle cells, or were irregularly shaped consisting of a mixture of cuboidal and columnar cells (d* -f*). LID/PTU: mice fed low iodine diet supplemented with 0.15% propylthiouracil (LID/PTU; Harlan Teklad formula # TD 95125) for a minimum of 2.5 months. Bar=1.5 mm. LID/PTU was fed to a group of mice to increase serum TSH levels in order to increase thyroid mass for molecular characterization and to accelerate PTC1-Y/F-induced phenotypes by increasing TSH-stimulated transgene expression and/or synergistic effects of TSH stimulation on PTC1 oncogenic activity. As expected, mice fed LID/PTU had hypertrophic and hyperplastic thyroids (a -f versus a* -f*). As all Tg-PTC1 transgenic mice from three different lines had evident tumor formation by 2 months of age (Jhiang et al., 1996) , characterization of mice in this study began at approximately the age of 2 months. Further, to address potential tumor formation latency, mice from a spectrum of ages were also characterized. To get a representative phenotype for each transgenic line, at least four mice per transgenic line were investigated. Following euthanasia, mouse thyroid tissues were removed, immediately fixed in 10% neutral-buffered formalin, and then embedded in paraffin. For histological characterization, 5 mm thyroid tissue sections were deparaffinized and then stained with hematoxylin and eosin. Histological grade assignments were confirmed by two co-authors in a blind review of all sections pY-294, 404 and 451 in RET/PTC1-induced thyroid tumor TLF Buckwalter et al compensated by alternative pathways and lead to thyroid tumor formation in vivo. Thus, these signals may be redundant or complementary, and the summation of these signals achieves maximal transforming activity of PTC1 in vivo.
Statistical analysis comparing thyroid histological grade with age, sex, diet and transgene type showed that the histological grade was most affected by the type of transgene. As shown in Table 1 , the frequency of tumor formation was significantly different among the five groups of mice (P50.0001). The sex of the mouse had no impact upon the histological grade (male versus female, P=0.132). The histological grades of the thyroid glands were slightly higher in mice fed LID/ PTU than mice fed a normal diet (P=0.018), contributed mainly by an increase in frequency of grade 2, not grade 3. Therefore, TSH stimulation of the thyroid gland may merely facilitate the detection of distorted follicles and do not promote tumor formation. However, LID/PTU had the highest impact on the increased histological grades in Tg-PTC1-Y404F transgenic mice, which may reflect the ability of TSH to activate PLCb (Berridge and Irvine, 1989), potentially compensating for the loss of PLCg activation by the Y404F mutation in this mutant. Histological grades of the thyroid glands were generally increased with Figure 3 Radioiodide accumulation in the thyroid glands of Tg-PTC1-Y/F mice. A decrease in radioiodide accumulation is seen in regions of distorted follicles or tumors. Serial thyroid sections were used for hematoxylin and eosin staining (a,c,e) and autoradiography (b,d,f). a -b: grade 1. c -d: grade 2. e -f: grade 3. Bar=1.5 mm. To analyse in vivo iodide accumulation activity, mice were injected intraperitoneally with 0.3 mCi of NaI 125 (Amersham) per gram of body weight. Following an incubation period (2 -6 h), mice were euthanized, thyroids were isolated, and immediately fixed in 10% neutral-buffered formalin in preparation for paraffin embedding. Deparaffinized, 5 mm tissue sections were coated with LM-1 emulsion (Amersham) and incubated at 48C for 3 -14 days. The micro-autoradiogram emulsions were then developed and counterstained with hematoxylin pY-294, 404 and 451 in RET/PTC1-induced thyroid tumor TLF Buckwalter et al increasing age of mice (compared mice with the ages of 0 -6 months, 6 -12 months, and older than 12 months, P=0.011). Mice with increasing age would have increased opportunity for 'additional hits', which may promote tumor formation contributing to increased histological grades. Nevertheless, the type of transgene is the predominant factor in determining the histological grade, indicating that the lower tumor formation rates in Tg-PTC1-Y/F mice are not merely contributed by a late onset of tumor formation.
Western blot analysis was performed comparing transgene expression, MAPK, phosphorylated MAPK (pMAPK), and tubulin in cultured cells and within mice thyroids. As shown in Figure 4a , PTC1 was readily detected in Cos-7 cells transfected with the PTC1 cDNA, but not in Cos-7 parental cells. While MAPK phosphorylation was detected in NGF treated PC12 cells, MAPK in untreated PC12 cells was not phosphorylated (Figure 4b ). Interestingly, while MAPK phosphorylation levels are generally increased by RET activation in several cell types, MAPK phosphorylation was decreased in Cos-7 cells transfected with PTC1, compared to parental Cos-7 cells (Figure 4a ). This finding indicates that acute expression of RET/PTC1 does not always lead to increased MAPK phosphorylation. The effect of the Y/F mutations on AKT activation was also investigated in Cos-7 cells transiently transfected with PTC1 or PTC1 Y/F mutants. While total AKT levels did not vary significantly between the samples, phosphorylated AKT (pAKT) levels were higher in cells expressing PTC1 or PTC1 Y404F compared to the parental Cos-7 cells, and cells expressing PTC1 Y294F or PTC1 Y451F (Figure 4d) . Therefore, pAKT levels in vitro appeared to correlate with the tumor formation rate in the Tg-PTC1-Y/F mice, in that Tg-PTC1-Y404F mice had a higher tumor formation rate than Tg-PTC1-Y294F and Tg-PTC1-Y451F mice.
The expression levels of PTC1, pMAPK, MAPK, and tubulin were investigated among transgenic group, diet and age of mice, and the average histological grade per transgenic line. As shown in Figures 4c and 5 , transgene expression levels were not generally increased in thyroids from mice fed LID/PTU compared to mice fed a normal diet. While the increased serum TSH level in mice fed LID/PTU would initially increase PTC1 expression in thyroid follicular cells, the increased expression of PTC1 would then de-differentiate the thyroid cells that would result in decreased Tg promoter activity and decreased PTC1 transgene expression. Indeed, when observing the grade 2 histology samples of mice fed LID/PTU (Figure 2) , it appeared that the distorted follicles were not responding to TSH stimulation in that they were usually neither hypertrophic nor hyperplastic, and usually retained a certain amount of colloid.
The only significant relationship found was between tubulin expression levels and animal diet. Upon equal amounts of total protein loading, tubulin expression levels were higher in thyroids of mice fed LID/PTU than mice fed a normal diet, reflecting increased cellularity in LID/PTU treated thyroids. The increase of thyroid cellularity in mice fed LID/PTU diet was also shown by histological analysis in Figure 2 . Assuming that the expression levels of tubulin reflect the cell numbers loaded in each sample, the expression levels of PTC1, phosphorylated MAPK and total MAPK were normalized by the expression levels of tubulin. Analysis of variance showed that histological grades do not correlate with the levels of PTC1 expression, pMAPK, or MAPK. Taken together, the inter-and intra-line variations in histological grades among Tg-PTC1-Y/F transgenic mice could not be simply explained by differences in transgene expression levels or the extent of MAPK phosphorylation. Total cell lysates or mouse thyroid proteins were resolved by SDS -PAGE and transferred to a nitrocellulose filter for Western blot analysis as described in Xing et al. (1998) . For figures a -c, the filter was sequentially stripped as described elsewhere (Sweetser et al., 1999) , reblocked and reprobed with the primary antibodies against pMAPK (Promega: 1 : 5000), MAPK (Santa Cruz Biotechnology: 1 : 500 K-23 pAb), or b-tubulin (Santa Cruz; 1 : 200 H-235 pAb), respectively. For figure d, the filters were probed with either anti-RET (C1 mouse monoclonal anti-RET antibody), or anti-AKT (Cell Signaling Technology: 1 : 1000), or Ser473-phospho-AKT (Cell Signaling Technology: 1 : 1000) primary antibody followed by appropriate secondary antibody and ECL substrate solution (Amersham). Densitometry analysis was performed using the NIH image analyzer computer program to quantify the expression levels of detected proteins pY-294, 404 and 451 in RET/PTC1-induced thyroid tumor TLF Buckwalter et al
Inter-line variations in tumor occurrence, although not observed in our Tg-PTC1 transgenic mice, have been commonly observed in transgenic mouse models due to differences in transgene copy number or integration site. However, we found no evident correlation between transgene expression levels and histological grades in Tg-PTC1-Y/F mice (for example, Tg-PTC1-Y294F-#40 versus Tg-PTC1-Y294F-#64, Tg-PTC1-Y451F-#57 versus Tg-PTC1-Y451F-#117 in Figure 5 ). While it is tempting to conclude that transgene expression levels do not have an impact on histological grades and thus tumor occurrence, this issue is complicated by the use of a thyroid-specific and TSH-responsive Tg promoter and the de-differentiation effect of PTC1 in thyroid follicular cells. It is more likely that a high level of transgene expression may initially play a critical role in inducing tumor formation; however, continued expression of the transgene is not required to maintain tumor formation in the thyroid gland. This would explain why PTC1 expression in thyroids of histological grade 3 was not always higher than thyroids of histological grade 1 and 2. A similar finding was observed by Powell et al. (2001) showing that continued expression of the PTC3 oncoprotein was not necessary for tumor progression in thyroid-targeted PTC3 transgenic mice.
Both onset and duration of transgene expression may play important roles in thyroid tumor formation. Kato et al. (1999) reported a correlation between the increased rate of tumor formation and the earlier expression of the RET oncogene under the control of the mouse metallothionein promoter. High levels of transgene expression and tumor formation before birth resulted in the animal's immune system failing to recognize the tumor, thus allowing tumor progression. In contrast, for mice with transgene expression levels that peaked after birth, the immune system recognized the transgene product as foreign and inhibited further tumor growth. Therefore, transgenic mice with a later onset of transgene expression would have a decreased rate of tumor formation. It is known that PTC1 expression in thyroid cells leads to activation of several common signaling pathways that are also modulated by many other factors. If the duration of PTC1 expression is inadequate, in particular the PTC1-Y/F mutant with a weaker oncogenic activity, the activated signaling pathways may be reversed by other factors produced by the thyroid follicular cells or their microenvironment. Therefore, the tumor formation in transgenic mice carrying PTC1-Y/F mutant with weaker oncogenic potential, in particular the ones with a short duration of transgene expression, would be greatly affected by the microenvironment. This may also explain the inter-line and intra-line variations of tumor formation rate in thyroid-targeted PTC1 transgenic mice using a weaker rat Tg promoter (Santoro et al., 1996) .
The fact that PTC1 has de-differentiation effects on thyroid follicular cells leading to decreased Tg promoter activity makes it difficult to perform in-depth biochemical analysis in thyroid tumors among different transgenic mouse lines. Lack of correlation between histological grades, transgene expression levels, and MAPK phosphorylation was also reported in RET/ NTG: non-transgenic mouse. L/P: Low iodine diet supplemented with propylthiouracil. kDa: kilodaltons. Hist. grade: histology grade. Western blot analysis was performed as described in the legend of Figure 4 pY-294, 404 and 451 in RET/PTC1-induced thyroid tumor TLF Buckwalter et al MEN2B transgenic mice (Sweetser et al., 1999) . Taken together, a thyroid-targeted, inducible PTC1 transgenic mouse model would be necessary to address the importance of expression levels, onset, and expression duration of PTC1, as well as the temporal profile of the corresponding signaling pathways in relation to thyroid tumor formation. However, our current study of Tg-PTC1-Y/F transgenic mice showed that signaling pathways mediated by pY294, pY404, or pY451, do play a role in PTC1-induced tumor formation in thyroid glands, but none of the signaling pathways mediated by pY294, pY404, or pY451, are solely essential for RET/PTC1-induced tumor formation.
